Clinical Research Directory

Inclusion Criteria: Individuals who meet all of the following criteria are eligible for enrollment as study participants: * Must be able to understand and provide written informed consent; * Anticipated listing for lung transplantation OR listed for lung transplant OR is within 45 days of having received a single or bilateral cadaveric donor lung transplant; * Undergoing first lung transplant operation; * Transplant surgery to be performed or performed at enrolling center; * Concurrent participation in CTOT-20 (Clinical Trials.gov ID: NCT02631720); and * CMV-seropositive lung transplant recipient, using methods in accordance with current local organ procurement organization policies. * Note: Concurrent participation in immune monitoring studies or interventional device trials are permitted. Exclusion Criteria: Individuals who meet any of the following criteria are not eligible for enrollment as study participants: * Unwilling to enroll in CTOT-20 (Clinical Trials.gov ID: NCT02631720); * Multi-organ recipient; * Prior recipient of any solid organ transplant, including prior lung transplant; * Prior or concurrent recipient of bone marrow transplant; * Human Immunodeficiency Virus (HIV) infection; * Pregnant or planned pregnancy; * Any condition that, in the investigator's opinion, would make it unlikely for the recipient to complete follow up procedures or complete the study; or * Participation in an investigational drug trial at the time of enrollment visit.